share_log

Vivos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

SEC ·  Feb 15 05:05
Summary by Futu AI
On December 31, 2023, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G with the SEC, disclosing a 9.99% ownership stake in Vivos Therapeutics, Inc., amounting to 175,099 shares. Armistice Capital, as the investment manager of Armistice Capital Master Fund Ltd., exercises voting and investment power over the securities held by the Master Fund. Steven Boyd, as the managing member of Armistice Capital, may also be deemed to beneficially own the securities held by the Master Fund. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Vivos Therapeutics. The filing was signed and dated February 14, 2024, by Steven Boyd, Managing Member of Armistice Capital, LLC.
On December 31, 2023, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G with the SEC, disclosing a 9.99% ownership stake in Vivos Therapeutics, Inc., amounting to 175,099 shares. Armistice Capital, as the investment manager of Armistice Capital Master Fund Ltd., exercises voting and investment power over the securities held by the Master Fund. Steven Boyd, as the managing member of Armistice Capital, may also be deemed to beneficially own the securities held by the Master Fund. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Vivos Therapeutics. The filing was signed and dated February 14, 2024, by Steven Boyd, Managing Member of Armistice Capital, LLC.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.